Shutterstock AI and Michael Annino

Strengthening pharma’s sustainability foundation

New tools can help seamlessly integrate sustainability into R&D and production goals

Be Sure To Read

Vaccines of the future

There is a new era of vaccinology in pharma's pipelines

2024 pharma predictions: Therapeutic advances, manufacturing tech

In our two-part series, leaders weigh in on what the pharma industry can expect in the coming year
Pm2303 Hero 854x480 Cover Story

Nevertheless, they persisted

How drugmakers are fighting to keep reproductive health drugs available, safe and legal

Anticipating AI regulations in pharma manufacturing

In a rapidly evolving regulatory landscape, leaders should remain ready to adapt to new legislation

FDA decisions to watch in 2024   

This year, the agency will decide on groundbreaking treatments for conditions like Alzheimer's, NASH, pulmonary hypertension and more

5 Pharma changemakers

The CNBC 2024 Changemakers list highlighted fifty women as transformative leaders, including five from the pharma industry

Cerevel Parkinson’s drug gets phase 3 win ahead of AbbVie deal

The drugmaker shared positive late-stage trial results for its D1/D5 receptor in Parkinson’s disease

Takeda inks immuno-oncology partnership with Kumquat

The oncology biotech could receive $1.2 billion in milestone payments and royalties on future sales

Eli Lilly weight loss drug significantly improves sleep apnea symptoms

The drugmaker shared that the trials demonstrated a reduction of up to 63% in the apnea-hypopnea index

GSK antibiotic hits phase 3 goals in gonorrhea

Gepotidacin, a potential first-in-class oral antibiotic, is already armed with two positive trials in UTIs


Pharma events calendar

Keep track of in-person industry events.

Pharma Innovation Awards

Now accepting submissions for 2024!

Funny Pharm

Submit your caption to cartoons created by award-winning artist Jerry King.


The latest content from industry thought leaders.

Editors' (re)View

Weekly takes on things going on in the pharma world.

Navigating data integrity compliance

Discover insights into FDA's Data Integrity Guidance and how to leverage the Cloud to achieve GMP compliance.

A Paperless Future: How Blue Mountain Revolutionized Asset Management at AmplifyBio

Discover how Blue Mountain's Regulatory Asset Manager (RAM) propelled AmplifyBio, a leading Contract Research Organization (CRO), into a paperless future.

Harnessing the Power of Industry 4.0 for Life Science

Leverage the latest advancements in technologies to drive innovation and deliver improved patient outcomes.

Innovate with confidence: Smoothing the path to successful mRNA manufacturing

mRNA-LNP manufacturing is fraught with obstacles, resulting in higher program risk, inflated costs, and delayed market release. With the right knowledge, companies can overcome...

5 ways dust collectors help ensure a controlled environment when tableting APIs

During tableting processes, APIs become airborne. These dust particles can harm workers, reduce air quality, contaminate products and cause explosions. Learn how dust collectors...

White paper: Stop sweating temperature excursions

Advanced chemical indicators give you the peace of mind that comes from reliable insights into your supply chains.

Excipient-based strategies to harness complex therapeutics

Though excipients are a necessary drug component that can often be taken for granted, the ever-changing pharma landscape is always pushing us to shift our perspectives.

Bringing down the barriers to process monitoring in biopharma

How modern process analytical technologies such as Raman spectroscopy can improve quality control
Screen Shot 2023 09 06 At 11 17 20 Am

Bridging the gap between R&D and GMP

Companies prioritizing optimized synthetic routes, stable API forms, and verified analytical tools set the stage for phase I clinical manufacturing success
Pm Article Option 4

7 challenges of NGS-based biomarkers

Next generation sequencing has unprecedented power in biology, but has yet to reach its full potential in medicine


Charting a sustainable path for generics

Key takeaways from the Association for Accessible Medicines’ Access! 2024 meeting
Contract Manufacturing

INCOG Biopharma: Pedaling towards excellence

The Indiana-based CDMO is redefining injectable drug manufacturing with community collaboration and technology
Contract Manufacturing

Cellares: A disruptive impact on cell therapy

The San Francisco-based IDMO says its differentiated technology will allow pharma companies to unlock massive productivity gains in cell therapy — and save the lives of millions...


Quality & Risk

[Slideshow] 5 steps to improve your contamination control strategy

A robust contamination control strategy isn't merely a guideline, it's a necessity
Microsoft Teams Image (7)

[Slideshow] Pharma Manufacturing's essential reference guide

Quick answers to all your pharma manufacturing questions
Shutterstock 749369605

[Slideshow] What keeps pharma up at night?

13 pharma scaries….and solutions that offer reprieve